Continues to devote entire life to public service through not-for-profit enterprises focused on the arts and education. Brand new to investing by way of very modest inheritance in a couple of handsfull of fairly conventional positions. Primary investment goal is to not lose the investment while learning about investments. At the end of the day, it would be a good thing to not be viewed as an idiot.
Shane Skinner has invested in biotech companies for almost 20 years and placed over $2.6 million in biotech stock trades in 2013. He has held various financial leadership positions over the past 17 years throughout the United States and Europe including Chief Financial Officer. Shane graduated from Pepperdine University with an MBA, York College with a bachelor's degree in accounting, and is a licensed CPA. He was a collegiate soccer and rugby player and still plays in recreational leagues in Seattle. He has a wife, son, and one on the way!
I just graduated WPI with a degree in Electrical and Computer Engineering. I work full-time as a Systems Engineer and will be pursuing a Master's Degree in Systems Engineering. I have recently become fascinated with investing. For me, its a different way to look at and analyze whats around me. My goal with investing is be able to fund traveling the world.
(as of 4/3/2014)
Here's hoping 2014 is a great year!
Drop a message or email Bryan_Myers@icloud.com. I'm always interested in chatting with other people about investing, business, ideas... anything.
Background in engineering, which after years quite honestly bored me. I consider myself a serial entrepreneur and avid day trader. Particularly interested in small biopharmaceutical & biotech. I travel extensively, and I do mean extensively and love every minute of it. Currently living between Singapore and Knoxville, TN.
Waiting for PVCT to get to $100 so I can retire. Doesn't seem like that will be too far away now!
I have an extensive background in Forex Account Management and a strong interest in the market. As a former Nurse, I have an interest in BioTech and Pharmaceutical companies that are emerging in the market.
Andrew McDonald is a healthcare investment professional with expertise in identifying transformative medicines as well as in forecasting clinical trial, regulatory, and sales outcomes. Prior to co-founding LifeSci Advisors, Andrew most recently served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, Andrew was Co-head of Healthcare Research and Biotechnology Analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, Andrew was a medicinal chemist at Cytokinetics from 2001-2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Andrew began his pharmaceutical career as a medicinal chemist at Pfizer from 2000-2001. Andrew received a Ph.D. in organic chemistry from UC Irvine and completed his B.S. in chemistry at UC Berkeley.